Videos
- Pharmacogenomic Testing for Major Depression: A Simulation Model
- Simulation Model of Treatments for Major Depression: Pharmacogenomic Testing and Beyond
News Stories & Features
Radio / Podcasts
- Interview with Shahzad Ghanbarian and Jehannine Austin on CMAJ Podcasts: “Pharmacogenomic testing: billion-dollar savings in depression treatment” – December 11, 2023
- Interview with Stirling Bryan featured in CBC’s Radio One – November 15, 2023
- Interview with Jehannine Austin on NiceGenes! Season 1 Episode 2: “The Right Meds” – June 2022
Print / Online
- UBC Medicine Featured Story: “Tailoring depression treatment” – July 8, 2024
- Genome BC Blog: “BC study to pave the way for tailored treatment of depression” – June 27, 2024
- UBC Beyond: “New genetic testing could tell you which antidepressant works best for you” – January 17, 2024
- Vancouver Sun: “Genetic testing could help patients with depression” – November 21, 2023
- UBC Medicine News: “Genetic testing could greatly benefit patients with depression, save health system millions” – November 14, 2023
Video
Infographics
View / download full sized versions by clicking the buttons:




Journal Publications
- Cost-Effectiveness
Ghanbarian S, Wong G W K, Bunka M, Edwards L, Cressman S, Conte T, Price M, Schuetz C, Riches L, Landry G, Erickson D, McGrail K, Peterson S, Vijh R, Hoens A M, Austin J, Bryan S. Cost-effectiveness of pharmacogenomic-guided treatment for major depression. CMAJ 2023
DOI: 10.1503/cmaj.221785 - Modelling Protocol
Ghanbarian S, Wong G W K, Bunka M, Edwards L, Cressman S, Conte T, Peterson S, Vijh R, Price M, Schuetz C, Erickson D, Riches L, Landry G, McGrail K, Austin J, Bryan S. A Canadian simulation model for major depressive disorder: Study protocol. Pharmacoeconomics 2024
DOI: 10.1007/s41669-024-004810-y - Patient Partner Perspectives
Riches L, Ridgway L, Edwards L. Co-learning commentary: a patient partner perspective in mental health care research. Research Involvement and Engagement 2023
DOI: 10.1186/s40900-023-00435-4 - Qualitative Study: Patient & Professional Perspectives
Slomp C, Morris E, Edwards L, Hoens A M, Landry G, Riches L, Ridgway L, Bryan S, Austin J. Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders. Canadian Journal of Psychiatry 2022
DOI: 10.1177/07067437221140383 - Rapid Systematic Review: Treatment Outcomes
Bunka M, Wong G, Kim D, Edwards L, Austin J, Doyle-Waters M M, Gaedigk A, Bryan S. Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: A rapid review and meta-analysis. Psychiatry Research 2023
DOI: 10.1016/j.psychres.2023.115102 - Costs of Major Depression in British Columbia
Cressman S, Ghanbarian S, Edwards L, Peterson S, Bunka M, Hoens A M, Riches L, Austin J, Vijh R, McGrail K, Bryan S. Costs of major depression covered / not covered in British Columbia, Canada. BMC Health Services Research 2023
DOI: 10.1186/s12913-023-10474-y - Reflection on Collaborative Experience in Modelling
Bunka M, Ghanbarian S, Riches L, Landry L, Edwards L, Hoens A M, Bryan S. Collaborating with Patient Partners to Model Clinical Care Pathways in Major Depressive Disorder: The Benefits of Mixing Evidence and Lived Experience. PharmacoEconomics 2022
DOI: 10.1007/s40273-022-01175-1